Podbean logo
  • Discover
  • Podcast Features

    Your all-in-one podcasting solution.
    Blog to Podcast

    Turn your blog into an engaging podcast.
  • Livestream

    High-performing audio live, without limits.
    Podcast Studio

    Easy-to-use audio recorder app.
  • Podbean AI

    AI-Enhanced Audio Quality and Content Generation.
    Podcast App

    The best podcast player & podcast app.
  • Ads Marketplace

    Join Ads Marketplace to earn money
    through sponsorship on your podcast.
    PodAds

    Manage your ads with dynamic ad insertion capability.
  • Apple Podcasts Subscriptions Integration

    Effortlessly publish and manage exclusive episodes for your
    Apple Podcasts subscribers directly from Podbean.

  • Live Streaming

    Receive livestream rewards from your audience and earn
    recurring income from your Fan Club membership.

  • All Arts Business Comedy Education
  • Fiction Government Health & Fitness History Kids & Family
  • Leisure Music News Religion & Spirituality Science
  • Society & Culture Sports Technology True Crime TV & Film
  • Live
  • How to Start a Podcast
  • How to Start a Live Podcast
  • How to Monetize a podcast
  • How to Promote Your Podcast
  • How to Use Group Recording
  • Log in
  • Start your podcast for free
  • Podcasting
    • Podcast Features
    • Livestream
    • Podbean AI
    • Blog to Podcast
    • Podcast Studio
    • Podcast App
  • Monetization
    • Ads Marketplace
    • Apple Podcasts Subscriptions Integration
    • Live Streaming
    • PodAds
  • Advertisers
  • Enterprise
  • Pricing
  • Discover
    • Log in
    Sign up free
ReachMD CME

ReachMD CME

Science & Medicine

Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC

Consolidative Immunotherapy Following sCRT vs RT Only in Stage III NSCLC

2024-05-15
Download Right click and do "save link as"
CME credits: 1.00
Valid until: 25-06-2025
Claim your CME credit at https://reachmd.com/programs/cme/consolidative-immunotherapy-following-scrt-vs-rt-only-in-stage-iii-nsclc/24388/

In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical data, and managing toxicities.

view more

More Episodes

Does Your Patient Have PBC?
2024-11-08
Empowering Choices: Navigating Early-Stage HR+, HER2- Breast Cancer with CDK4/6 Inhibition
2024-10-31
Pulmonary Hypertension for Advanced Practice Providers: Risk Stratification and Diagnosis to Enhance Quality of Care and Outcomes
2024-10-17
Patient-Centric Approaches to Optimizing Outcomes in AAD: Case Review
2024-10-15
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
2024-10-11
Advancing Cystic Fibrosis: Addressing Disparities, Challenging Perceptions, and Innovating Patient-Centered Care
2024-10-11
Bringing Treatment Into Focus: Biomarker-Driven First-Line Therapy for Metastatic Gastric/GEJ Cancers
2024-10-04
Navigating COPD: From Symptom Recognition to Emerging Treatment Strategies
2024-10-04
The Evolving Role of MET TKIs in NSCLC
2024-10-02
Chairperson's Perspective: Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metastatic Breast Cancer
2024-09-30
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
2024-09-25
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management
2024-09-25
Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
2024-09-24
How Antibody-Based Therapies Are Revolutionizing Its Management
2024-09-18
Targeting Resistance in EGFRm NSCLC with HER3-Directed ADCs in the Community Setting
2024-09-13
Significance of HER2 Expression in Solid Tumors
2024-08-30
Diversity in HER2 Expression Among Gynecologic Cancers
2024-08-30
Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors
2024-08-30
Emerging Data Evaluating HER2-Directed Therapies in Gynecologic Cancers
2024-08-30
Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?
2024-08-30
  • ←
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • →
012345678910111213141516171819

Get this podcast on your
phone, FREE

Download Podbean app on App Store Download Podbean app on Google Play

Create your
podcast in
minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get started

It is Free

  • Podcast Services

    • Podcast Features
    • Pricing
    • Enterprise Solution
    • Private Podcast
    • The Podcast App
    • Live Stream
    • Audio Recorder
    • Remote Recording
    • Podbean AI
  •  
    • Create a Podcast
    • Video Podcast
    • Start Podcasting
    • Start Radio Talk Show
    • Education Podcast
    • Church Podcast
    • Nonprofit Podcast
    • Get Sermons Online
    • Free Audiobooks

  • MONETIZATION & MORE

    • Podcast Advertising
    • Dynamic Ads Insertion
    • Apple Podcasts Subscriptions
    • Switch to Podbean
    • YouTube to Podcast
    • Blog to Podcast
    • Submit Your Podcast
    • Podbean Plugins
    • Developers

  • KNOWLEDGE BASE

    • How to Start a Podcast
    • How to Start a Live Podcast
    • How to Monetize a Podcast
    • How to Promote Your Podcast
    • Mobile Podcast Recording Guide
    • How to Use Group Recording
    • Podcast Advertising 101

  • Support

    • Support Center
    • What’s New
    • Free Webinars
    • Podcast Events
    • Podbean Academy
    • Podcasting Smarter
    • Badges
    • Resources

  • Podbean

    • About Us
    • Podbean Blog
    • Careers
    • Press and Media
    • Green Initiative
    • Affiliate Program
    • Contact Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Use
  • Consent Preferences
  • Copyright © 2015-2024 Podbean.com